Cancer Prevention Education for Breast and Cervical Cancer
(SEMM2 Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to increase early detection and prevention of breast and cervical cancer through education and navigation and to increase breast and cervical cancer screening and Human Papillomavirus (HPV) vaccination in underserved Latinas.
Research Team
Lara Savas, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Eligibility Criteria
This trial is for Latina women in certain Texas counties who are over 40 with no mammogram in the last 2 years, aged 21-65 with no Pap test in the past 3 years, or aged 18-26 (up to age 45 if recommended) needing HPV vaccination. Pregnant women or those with a current/past cancer diagnosis cannot join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Education (Behavioral Intervention)
- Navigation to clinic (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
Dr. LaTanya Love
The University of Texas Health Science Center, Houston
Interim President
MD from UT Medical Branch in Galveston
Dr. Jagat Narula
The University of Texas Health Science Center, Houston
Chief Academic Officer since 2023
MD, PhD
Cancer Prevention Research Institute of Texas
Collaborator